{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:18:42Z","timestamp":1792185522607,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T00:00:00Z","timestamp":1498003200000},"content-version":"vor","delay-in-days":385,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.immuni.2016.05.014","type":"journal-article","created":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T14:02:40Z","timestamp":1466517760000},"page":"1444-1454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":554,"title":["Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma"],"prefix":"10.1016","volume":"44","author":[{"suffix":"Jr.","given":"Avery\u00a0D.","family":"Posey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert\u00a0D.","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina\u00a0C.","family":"Boesteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Steentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Engels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer\u00a0D.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas\u00a0D.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen\u00a0M.","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria\u00a0P.","family":"Cogdill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor\u00a0J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Scholler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David\u00a0M.","family":"Kranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael\u00a0D.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Keith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura\u00a0A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl\u00a0H.","family":"June","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2016.05.014_bib1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/his.12330","article-title":"Expression of Mucin-1 in multiple myeloma and its precursors: correlation with glycosylation and subcellular localization","volume":"64","author":"Andrulis","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.immuni.2016.05.014_bib2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/glycob\/cwr182","article-title":"Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family","volume":"22","author":"Bennett","year":"2012","journal-title":"Glycobiology"},{"key":"10.1016\/j.immuni.2016.05.014_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0925-4439(99)00069-1","article-title":"Tn-syndrome","volume":"1455","author":"Berger","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.immuni.2016.05.014_bib4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1021\/cb300076s","article-title":"Deciphering structural elements of mucin glycoprotein recognition","volume":"7","author":"Borgert","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.immuni.2016.05.014_bib5","doi-asserted-by":"crossref","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T\u00a0cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2016.05.014_bib6","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1073\/pnas.0813101106","article-title":"Control of large, established tumor xenografts with genetically retargeted human T\u00a0cells containing CD28 and CD137 domains","volume":"106","author":"Carpenito","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2016.05.014_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/bcr2577","article-title":"Tumour-associated carbohydrate antigens in breast cancer","volume":"12","author":"Cazet","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.immuni.2016.05.014_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2141.2006.06331.x","article-title":"Cancer specific Mucin-1 glycoforms are expressed on multiple myeloma","volume":"135","author":"Cloosen","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.immuni.2016.05.014_bib9","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1200\/JCO.2009.23.3494","article-title":"Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation","volume":"27","author":"Emens","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.immuni.2016.05.014_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12026-011-8214-1","article-title":"Importance of MUC1 and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomas","volume":"50","author":"Finn","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.immuni.2016.05.014_bib11","doi-asserted-by":"crossref","first-page":"E3152","DOI":"10.1073\/pnas.1305269110","article-title":"Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness","volume":"110","author":"Gill","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2016.05.014_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s002620050254","article-title":"The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine","volume":"42","author":"Graham","year":"1996","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.immuni.2016.05.014_bib13","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T\u00a0cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2016.05.014_bib14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.leu.2403302","article-title":"Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia","volume":"18","author":"Imai","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.immuni.2016.05.014_bib15","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1097\/00004836-200305001-00012","article-title":"Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice","volume":"36","author":"Itzkowitz","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.immuni.2016.05.014_bib16","doi-asserted-by":"crossref","first-page":"16613","DOI":"10.1073\/pnas.262438199","article-title":"A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase","volume":"99","author":"Ju","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2016.05.014_bib17","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/4371252a","article-title":"Protein glycosylation: chaperone mutation in Tn syndrome","volume":"437","author":"Ju","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2016.05.014_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1074\/jbc.M109056200","article-title":"Purification, characterization, and subunit structure of rat core 1 Beta1,3-galactosyltransferase","volume":"277","author":"Ju","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2016.05.014_bib19","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1158\/0008-5472.CAN-07-2345","article-title":"Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc","volume":"68","author":"Ju","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2016.05.014_bib20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/glycob\/cwq168","article-title":"A novel fluorescent assay for T-synthase activity","volume":"21","author":"Ju","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.immuni.2016.05.014_bib21","doi-asserted-by":"crossref","first-page":"280ps7","DOI":"10.1126\/scitranslmed.aaa3643","article-title":"Adoptive cellular therapy: a race to the finish line","volume":"7","author":"June","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2016.05.014_bib22","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells expressing chimeric receptors establish memory and potent antitumor effects in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2016.05.014_bib23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1349-7006.2009.01455.x","article-title":"Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers","volume":"101","author":"Kannagi","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.immuni.2016.05.014_bib24","first-page":"1251","article-title":"Transduction of a novel HLA-DRB1\u221704:05-restricted, WT1-specific TCR gene into human CD4+ T\u00a0cells confers killing activity against human leukemia cells","volume":"35","author":"Katsuhara","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.immuni.2016.05.014_bib25","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","article-title":"Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T\u00a0cells genetically engineered to recognize CD19","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2016.05.014_bib26","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/mt.2013.17","article-title":"Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T\u00a0cells: clinical evaluation and management of on-target toxicity","volume":"21","author":"Lamers","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.immuni.2016.05.014_bib27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/his.12309","article-title":"Reciprocal relationship of Tn\/NF-\u03baB and sTn as an indicator of the prognosis of oral squamous cell carcinoma","volume":"64","author":"Lin","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.immuni.2016.05.014_bib28","doi-asserted-by":"crossref","first-page":"e72413","DOI":"10.1371\/journal.pone.0072413","article-title":"Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing","volume":"8","author":"Madsen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.immuni.2016.05.014_bib29","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T\u00a0cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2016.05.014_bib30","doi-asserted-by":"crossref","first-page":"41523","DOI":"10.1074\/jbc.M112.371989","article-title":"Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen","volume":"287","author":"Mi","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2016.05.014_bib31","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/mt.2009.83","article-title":"Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T\u00a0cells and increased antileukemic efficacy in\u00a0vivo","volume":"17","author":"Milone","year":"2009","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.immuni.2016.05.014_bib32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/mt.2010.24","article-title":"Case report of a serious adverse event following the administration of T\u00a0cells transduced with a chimeric antigen receptor recognizing ERBB2","volume":"18","author":"Morgan","year":"2010","journal-title":"Mol. Ther."},{"issue":"6A","key":"10.1016\/j.immuni.2016.05.014_bib33","first-page":"4047","article-title":"Expression of Tn and sialyl-Tn antigens in endometrial cancer: its relationship with tumor-produced cyclooxygenase-2, tumor-infiltrated lymphocytes and patient prognosis","volume":"26","author":"Ohno","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.immuni.2016.05.014_bib34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2006.08.019","article-title":"Glycosylation in cellular mechanisms of health and disease","volume":"126","author":"Ohtsubo","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2016.05.014_bib35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4049\/jimmunol.171.1.166","article-title":"CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4\u00a0T lymphocytes","volume":"171","author":"Parry","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2016.05.014_bib36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T\u00a0cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2016.05.014_bib37","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.immuni.2012.03.004","article-title":"Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer","volume":"36","author":"Rabinovich","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2016.05.014_bib38","doi-asserted-by":"crossref","first-page":"E4066","DOI":"10.1073\/pnas.1406619111","article-title":"Immature truncated O-glycophenotype of cancer directly induces oncogenic features","volume":"111","author":"Radhakrishnan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2016.05.014_bib39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/iub.1268","article-title":"ST6GalNAcII mediates the invasive properties of breast carcinoma through PI3K\/Akt\/NF-\u03baB signaling pathway","volume":"66","author":"Ren","year":"2014","journal-title":"IUBMB Life"},{"key":"10.1016\/j.immuni.2016.05.014_bib40","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1158\/1078-0432.CCR-06-2949","article-title":"Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer","volume":"13","author":"Sabbatini","year":"2007","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.immuni.2016.05.014_bib41","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/science.1129200","article-title":"A mutant chaperone converts a wild-type protein into a tumor-specific antigen","volume":"314","author":"Schietinger","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.immuni.2016.05.014_bib42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/glycob\/cwj044","article-title":"Chemoenzymatically synthesized multimeric Tn\/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance","volume":"16","author":"S\u00f8rensen","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.immuni.2016.05.014_bib43","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1126\/science.6729450","article-title":"T and Tn, general carcinoma autoantigens","volume":"224","author":"Springer","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.immuni.2016.05.014_bib44","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4161\/onci.20592","article-title":"A sensitivity scale for targeting T\u00a0cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)","volume":"1","author":"Stone","year":"2012","journal-title":"OncoImmunology"},{"key":"10.1016\/j.immuni.2016.05.014_bib45","article-title":"RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells","author":"Tamura","year":"2014","journal-title":"Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association"},{"key":"10.1016\/j.immuni.2016.05.014_bib46","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbagen.2007.09.010","article-title":"Mucin-type O-glycosylation and its potential use in drug and vaccine development","volume":"1780","author":"Tarp","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.immuni.2016.05.014_bib47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/glycob\/cwl061","article-title":"Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat","volume":"17","author":"Tarp","year":"2007","journal-title":"Glycobiology"},{"key":"10.1016\/j.immuni.2016.05.014_bib48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0925-4439(99)00055-1","article-title":"MUC1 and cancer","volume":"1455","author":"Taylor-Papadimitriou","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.immuni.2016.05.014_bib49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2559.2010.03667.x","article-title":"Expression of aberrantly glycosylated Mucin-1 in ovarian cancer","volume":"57","author":"Van Elssen","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.immuni.2016.05.014_bib50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-0215(19960126)65:3<295::AID-IJC3>3.0.CO;2-V","article-title":"Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer","volume":"65","author":"Victorzon","year":"1996","journal-title":"International journal of cancer. Journal international du cancer"},{"key":"10.1016\/j.immuni.2016.05.014_bib51","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/0008-5472.CAN-09-2893","article-title":"Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes","volume":"70","author":"Wandall","year":"2010","journal-title":"Cancer Res."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761316302023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761316302023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T23:20:44Z","timestamp":1536621644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761316302023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1074761316302023"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2016.05.014","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726441373.793522629","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2016.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}